drugset
drugset / Trial / NCT01375244

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

NCT01375244 ↗

Phase 1 Completed 36 enrolled Par Pharmaceutical, Inc. PharmaKinetics Laboratories Inc. · collab
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare the bioavailability of Par Lisinopril 10 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).

Timeline

Start
1999-06
Primary completion
1999-10
Completion
1999-10

Drugs

EvaluationDrugModalityDoseRoute
Subject LISINOPRIL ANHYDROUS Small molecule 10 mg Oral

Indications

No indication recorded.